BLNC — Balance Labs Share Price
- $3.97m
- $6.41m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | n/a |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 1 | 0.62 | 0.25 | n/a | n/a | n/a | n/a | -100% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Balance Labs, Inc. is a consulting company. It provides business development and consulting services to startup and development-stage businesses. It provides businesses in various industries with customized consulting services to meet their business needs and help them improve their business models, sales and marketing plans and internal operations, and introduces businesses to experienced professional contacts, which improves their businesses. Its services include business model development, including market research, naming and branding; business plan writing; financial modeling; Website and mobile app development; employee and board member recruitment; patent/trademark filing assistance; professional introductions; product or service development; product production; develop marketing material; product or service placement; celebrity endorsements, and introductions to professional services. It also seeks to offer executive office sharing and additional ancillary services.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 5th, 2014
- Public Since
- October 20th, 2015
- No. of Shareholders
- 52
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 21,674,000

- Address
- 1111 Lincoln Rd Fl 4, MIAMI BEACH, 33139-2439
- Web
- https://www.balancelabs.co/
- Phone
- +1 3059077600
- Auditors
- Assurance Dimensions
Upcoming Events for BLNC
Q2 2025 Balance Labs Inc Earnings Release
Similar to BLNC
1PM Industries
Pink Sheets on Nasdaq
3Dshopping.Com
Pink Sheets on Nasdaq
3 Sixty Risk Solutions
Pink Sheets on Nasdaq
Adecco AG
Pink Sheets on Nasdaq
Adm Endeavors
Pink Sheets on Nasdaq
FAQ
As of Today at 19:29 UTC, shares in Balance Labs are trading at $0.18. This share price information is delayed by 15 minutes.
Shares in Balance Labs last closed at $0.18 and the price had moved by -20.43% over the past 365 days. In terms of relative price strength the Balance Labs share price has underperformed the S&P500 Index by -26.22% over the past year.
There is no consensus recommendation for this security.
Find out moreBalance Labs does not currently pay a dividend.
Balance Labs does not currently pay a dividend.
Balance Labs does not currently pay a dividend.
To buy shares in Balance Labs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.18, shares in Balance Labs had a market capitalisation of $3.97m.
Here are the trading details for Balance Labs:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: BLNC
Based on an overall assessment of its quality, value and momentum Balance Labs is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Balance Labs. Over the past six months, its share price has outperformed the S&P500 Index by +0.82%.
As of the last closing price of $0.18, shares in Balance Labs were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Balance Labs PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.18.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Balance Labs' directors